rss
Evid Based Nurs doi:10.1136/eb-2013-101595
  • Midwifery
  • Cohort study

Late pregnancy use of selective serotonin reuptake inhibitors and serotonin and norepinephrine reuptake inhibitors is associated with increased risk of postpartum haemorrhage

  1. Alexander M Friedman
  1. Department of Obstetrics and Gynecology, College of Physicians and Surgeons, Columbia University, New York, New York, USA
  1. Correspondence to: Professor Cande V Ananth, Department of Obstetrics and Gynecology, College of Physicians and Surgeons, Columbia University, 622 West 168th Street, New York, NY 10032, USA; cande.ananth{at}columbia.edu

Commentary on:

Implications for research and practice

  • Use of antidepressant medication is associated with increased risk for postpartum haemorrhage (PPH).

  • Further research is needed to establish a causal role between antidepressant medication use and PPH.

  • Clinicians should be aware of possible increased risk of postpartum haemorrhage when treating depression during pregnancy.

Context

Antidepressant medications are commonly used to manage psychiatric conditions in pregnancy. While extensive research related to teratogenesis and neonatal outcomes has been undertaken,1 there is relatively few data related to maternal obstetrical outcomes. Research from other specialties suggests that serotonin reuptake inhibitors (SSRIs) …

Free Sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EBN.
View free sample issue >>

EBN Journal Chat

The EBN Journal Chat offers readers the opportunity to participate in discussion about research articles and commentaries from Evidence Based Nursing (EBN).

How to participate >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article